| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |